AN2 Therapeutics, Inc. - Common Stock, par value $0.00001 per share (ANTX)

CUSIP: 037326105

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / Common Stock, par value $0.00001 per share
Shares outstanding
37,347,828
Total 13F shares
18,733,564
Share change
-1,657,939
Total reported value
$60,875,021
Price per share
$3.25
Number of holders
54
Value change
-$18,042,573
Number of buys
31
Number of sells
31

Quarterly Holders Quick Answers

What is CUSIP 037326105?
CUSIP 037326105 identifies ANTX - AN2 Therapeutics, Inc. - Common Stock, par value $0.00001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AN2 Therapeutics, Inc. - Common Stock, par value $0.00001 per share (ANTX) as of Q1 2024

As of 31 Mar 2024, AN2 Therapeutics, Inc. - Common Stock, par value $0.00001 per share (ANTX) was held by 54 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 18,733,564 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., CITADEL ADVISORS LLC, TCG Crossover Management, LLC, Frazier Life Sciences Management, L.P., BVF INC/IL, JANUS HENDERSON GROUP PLC, Avidity Partners Management LP, Octagon Capital Advisors LP, VANGUARD GROUP INC, and ADAGE CAPITAL PARTNERS GP, L.L.C.. This page lists 54 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.